Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Is it virtuous to be virtual? The VC viewpoint

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Booth, B.L. Nat. Biotechnol. 27, 705–709 (2009).

    CAS  Article  Google Scholar 

  2. Booth, B. Nat. Biotechnol. 25, 853–857 (2007).

    CAS  Article  Google Scholar 

  3. Klausner A. Nat. Biotechnol. 27, 125–127 (2009).

    CAS  Article  Google Scholar 

  4. Christenson, C. et al. The Innovator's Prescription: A Disruptive Solution for Health Care (McGraw-Hill, New York, 2009).

    Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the valuable comments of Z. Lynch, B. Booth, K. Perampaladas and H. Masum in shaping the overall study design and G. Williams for study data. This study was supported by New Enterprise Associates. J.C. is funded by a grant from the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health initiative. We also graciously thank all the venture capital firms for participating in our qualitative and quantitative analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Justin Chakma.

Ethics declarations

Competing interests

New Enterprise Associates and Scale Venture Partners are investment firms that invest in biotech companies and biotech and A.B. and J.L.C. have a pecuniary interest in the success of their respective funds. Innovative Neurotechnologies is a virtual biotech startup and S.M. has a pecuniary interest in the success of that company.

Supplementary information

Supplementary Text and Figures

Supplementary Data (PDF 120 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chakma, J., Calcagno, J., Behbahani, A. et al. Is it virtuous to be virtual? The VC viewpoint. Nat Biotechnol 27, 886–888 (2009). https://doi.org/10.1038/nbt1009-886

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1009-886

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing